AequoScreen Cells, opioid kappa receptor, human recombinant, HEK293

爱游戏平台注册登录 ’s AequoScreen^® double transfected cell lines are provided in two vials of frozen cells, each containing ∽2.5 x 10⁶ cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available for each cell line.

The AequoScreen technology is a generic GPCR technology that can be used with G_s, G_i, and G_q-coupled GPCRs and calcium coupled ion channels. Following receptor stimulation, increases in intracellular calcium enable measurement of the resulting flash luminescence signal.

Features:

• Fully automatable and miniaturizable to 1536
• Enables reduction in reagents and consumable costs
• High signal to background ratio enabling detection of agonists, antagonists and allosteric modulators
• Robust assay (Z′, CV values, solvent resistance)
• Reduces the number of false positives from autofluorescent compounds in screening libraries
• Option to work with cells in suspension to increase throughput
• Amenable for use with calcium coupled ion channels and tyrosine kinase receptors

爱游戏平台注册登录 ’s AequoScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Contact us using the Request More Information button above for additional information regarding required documentation.